Letko, Brosseau & Associates Inc Gilead Sciences, Inc. Transaction History

Letko, Brosseau & Associates Inc

$5.37 Billion
Q3 2024

A detailed history of Letko, Brosseau & Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 976,178 shares of GILD stock, worth $90.4 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

976,178

Previous 967,533 0.89%

Holding current value

$90.4 Million

Previous $66.4 Million 23.26%

% of portfolio

1.52%

Previous 1.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $575,670 - $726,093	8,645 Added 0.89%	976,178 $81.8 Million
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $1.08 Million - $1.24 Million	17,075 Added 1.8%	967,533 $66.4 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $238,361 - $290,675	3,330 Added 0.35%	950,458 $69.6 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $1.74 Million - $1.98 Million	-23,787 Reduced 2.45%	947,128 $76.7 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $142,334 - $155,289	-1,925 Reduced 0.2%	970,915 $72.8 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $805,706 - $919,020	-10,600 Reduced 1.08%	972,840 $75 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $1.44 Million - $1.64 Million	-18,663 Reduced 1.86%	983,440 $81.6 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $20 Million - $28.7 Million	-320,320 Reduced 24.22%	1,002,103 $86 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $1.77 Million - $2.03 Million	-29,790 Reduced 2.2%	1,322,423 $81.6 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $10.8 Million - $12.2 Million	187,335 Added 16.08%	1,352,213 $83.6 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $1.27 Million - $1.59 Million	-21,893 Reduced 1.84%	1,164,878 $69.3 Million
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $588,786 - $668,283	-9,075 Reduced 0.76%	1,186,771 $86.2 Million
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $3.93 Million - $4.24 Million	-58,120 Reduced 4.63%	1,195,846 $83.5 Million
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $646,759 - $706,676	-10,190 Reduced 0.81%	1,253,966 $86.3 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $7.62 Million - $8.69 Million	126,918 Added 11.16%	1,264,156 $81.7 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $7.8 Million - $8.88 Million	-137,644 Reduced 10.8%	1,137,238 $66.3 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $9.69 Million - $12.2 Million	-156,055 Reduced 10.91%	1,274,882 $80.6 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $8.56 Million - $9.94 Million	-118,275 Reduced 7.63%	1,430,937 $110 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.22 Million - $1.56 Million	-19,410 Reduced 1.24%	1,549,212 $116 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $10.2 Million - $11.2 Million	165,277 Added 11.78%	1,568,622 $102 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $1.58 Million - $1.75 Million	25,325 Added 1.84%	1,403,345 $88.9 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $2.51 Million - $2.81 Million	-40,561 Reduced 2.86%	1,378,020 $93.1 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $989,974 - $1.11 Million	15,832 Added 1.13%	1,418,581 $92.2 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $407,010 - $531,117	6,723 Added 0.48%	1,402,749 $87.7 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $2.28 Million - $2.53 Million	-32,020 Reduced 2.24%	1,396,026 $108 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $3.56 Million - $4.16 Million	54,925 Added 4.0%	1,428,046 $101 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $693,801 - $845,820	-9,525 Reduced 0.69%	1,373,121 $104 Million
Q4 2017 Feb 20, 2018	SELL	$71.15 - $83.52 $914,633 - $1.07 Million	-12,855 Reduced 0.92%	1,382,646 $99.1 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $101 Million - $119 Million	1,395,501	1,395,501 $113 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Account

Letko, Brosseau & Associates Inc Gilead Sciences, Inc. Transaction History